Navigate Select ESC Close

A 40% Energy Rescue for the Aging Brain in Clinical Trial | Dr Stephen Cunnane

2026-05-13 Science & Technology
32
4
1
Modern Healthspan
Modern Healthspan
108.0k subscribers

Unlock all features

FREE: Get instant access to 10 AI summaries, chats, or transcripts per day.

Description

Dr. Stephen Cunnane discusses the landmark "Benefit Trial," the longest controlled study of MCT oil in patients with Mild Cognitive Impairment (MCI), showing a 40% reduction in the brain's energy deficit. Some links are affiliate links so we will earn a commission when they are used to purchase products. If you would like to support our channel please consider joining our Patreon https://patreon.com/ModernHealthspan ~~~~~~~~~~~~~~ *Qitone* (10% off: HEALTH10) https://tidd.ly/4jGklry Qitone Esters Powder *Renue By Science* (10% off: MHS) https://tinyurl.com/ywpemydv - Skin Essentials - Collagen & Creatine *BiOptimizers* (15% off: MHBIO) https://bit.ly/47VAa8f - Magnesium Breakthrough These are affiliate links - using them supports the channel at no extra cost to you. ~~~~~~~~~~~~~~ Dr. Stephen Cunnane (Université de Sherbrooke) breaks down the results of the Alzheimer’s Association-funded "Benefit Trial." The study addressed a critical issue in brain aging: the "energy gap" where the brain struggles to uptake glucose but remains capable of utilizing ketones. Using advanced PET imaging, researchers tracked how 30g of daily MCT oil (C8 and C10) functioned as a "dual-fuel" for the brain. The findings revealed that at peak levels, the intervention corrected the brain energy gap by up to 40%, with significant positive correlations in memory, executive function, and language performance. Dr. Cunnane explains the practical challenges of the study, from formulating a stabilized MCT milk emulsion to managing the 24-hour "metabolic curve." This clip offers a fascinating look at how exogenous ketones can provide a rescue fuel for those experiencing the earliest stages of cognitive decline. Note: This is an educational review of clinical research and not medical advice. While metabolic improvements were significant, Dr. Cunnane notes that cognitive outcomes were a secondary measure and the study was focused on metabolic status rather than clinical Alzheimer’s prevention. *Medical Disclaimer:* This video is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or the use of supplements like MCT oil. *RESEARCH NOTICE*: This discussion features Dr. Stephen Cunnane's work on brain energetics. The PET imaging discussed (FDG-PET) is a standard clinical tool used to observe the 25% decline in glucose utilization often seen in the parietal cortex during cognitive decline. 📚 Chapters 0:00 The BENEFIC Trial Overview 1:49 Metabolic Outcomes & Cognitive Results 3:23 The Intervention: MCT Protocol 5:26 How Much Does MCT Close the Energy Gap? 8:03 Why C8 & C10 & The Placebo Challenge 🌐Links in this video Peer review research cited: Title: A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6‐month RCT Link : https://pmc.ncbi.nlm.nih.gov/articles/PMC8048678/ DOI: 10.1002/alz.12206 Title: Improved brain energetics and cognition after a 6-month ketogenic intervention in mild cognitive impairment: Final results of the Benefic Trial Link: https://alz-journals.onlinelibrary.wiley.com/doi/abs/10.1002/alz.037961 DOI: 10.1002/alz.037961 Title: A reduced carbohydrate diet improves glycemic regulation in hyperglycemic older people in a retirement home: the SAGE study Link: https://cdnsciencepub.com/doi/10.1139/apnm-2024-0277 DOI: 10.1139/apnm-2024-0277 #Longevity #BrainHealth #Alzheimers

Top Comments (3)

@ccamire 2026-05-13

Our company in Canada worked on C10 for a decade for cancer and other applications, unfortunately the product was never developed because of patents. It would have been great product but the lack of funding for supplements killled the trials

6 1 replies
@RichardS-q6v 2026-05-13

Under inflammatory conditions mitochondria can utilise ketones more effectively than glucose. An interesting question would be to what degree is the energy gap modulated by inflammation. I've been treating my mothers dementia for 8 years. One of her dementia symptoms are seizures.The hypothesis for why the seizures happen is that her left temporal lobe experiences inflammation which creates an energy gap that causes it to desynchronise with the rest of the brain. The seizures are a consequence of the brain attempting to resynchronise with that slowed brain region. One of the interventions we tried was MCT and the ketogenic diet. On keto the gap between seizures extended by 50% and while she was in seizure we could bring her back to 100% by giving her MCT. The effect lasted maybe 45 minutes and then she was back to her seizure state. Her cognition was significantly better on keto.

3
@ModernHealthspan 2026-05-13

If you would like to support our channel please consider joining our Patreon https://patreon.com/ModernHealthspan *Qitone* (10% off: HEALTH10) https://tidd.ly/4jGklry Qitone Esters Powder *Renue By Science* (10% off: MHS) https://tinyurl.com/ywpemydv - Skin Essentials - Collagen & Creatine *BiOptimizers* (15% off: MHBIO) https://bit.ly/47VAa8f - Magnesium Breakthrough These are affiliate links - using them supports the channel at no extra cost to you.

0

Unlock the Data Inside
Turn Videos into Knowledge

  • Get FREE 10/day: transcripts, summaries, chats
  • Chat with videos, export text & PDF
  • $1 free API credit for RAG, chatbots & research

Free forever plan • All features unlocked

App screenshot